Skip to content
TLRY

Tilray Brands, Inc.

Tilray Brands, Inc. Q3 FY2025 earnings call

April 8, 2025 · fiscal period ended 2025-02

EPS · actual vs est

$-0.10 / $-0.04Miss -150.0%

Revenue · actual vs est

$185.8M / $249.7MMiss -25.6%
Ask about this call

Summary

Generated 2025-04-08

Management highlights

Management Statement and Operational Highlights

  • Company Diversification: Tilray has diversified into beverage, cannabis, and wellness, focusing on profitability over short-term growth.
  • Cannabis Segment: Strong gross margin growth in international markets, strategic allocation of cannabis to higher margin markets, and vertical integration.
  • Beverage Segment: Project 420 initiative for SKU rationalization, geographic consolidation, and cost savings. Growth in certain brands (e.g., craft lite lagers, non-alcoholic beers).
  • Wellness Segment: Steady growth with innovation (e.g., Manitoba Harvest, Highball Energy).
  • Technology and Innovation: AI implementation in greenhouses, cryptocurrency payment exploration, and focus on operational efficiencies.
View in transcript ↓

Segment performance

Segment Performance

  • Beverage: Net revenue was $55.9 million, but would have exceeded $60 million without strategic decisions. Gross profit increased, and gross margin was 36%.
  • Cannabis: Global cannabis net revenue was $54.3 million (constant currency $57 million). Gross margin was 41%, up 800 basis points. International and strategic decisions drove margin improvements.
  • Distribution: Net revenue was $61.5 million, up ~8% year-over-year.
  • Wellness: Net revenue was $14.1 million, up 5% year-over-year, with 8% growth on constant currency. Gross margin was 32%.
View in transcript ↓

Guidance

Guidance

  • Revised fiscal 2025 net revenue guidance to $850 million to $900 million, adjusting for strategic initiatives and skew rationalization.
View in transcript ↓

Risks

Risks

  • Market volatility and perception of reduced likelihood of US/European cannabis regulatory change leading to non-cash impairment.
  • Tariffs and competition in international markets, including pricing pressures and supply chain challenges.
View in transcript ↓

Q&A highlights

Question and Answer

Q: Allocation of cannabis product and share aspirations in Canada A: Focus on profitability and strategic product allocation, with Canada remaining important but international markets offering higher margins.

Q: Hemp-derived THC beverages growth and marketing A: Over 1,000 distribution points, regional marketing, sponsorships, and focus on educating consumers.

Q: Cannabis gross margin expansion A: Mix shifts, avoiding margin-dilutive categories, cost savings from extraction projects, and focus on profitability.

Q: Beverage sales and project 420 allocation of marketing dollars A: Skew rationalization affecting sales, focus on bigger brands and regional growth, with strategic brand investments.

Q: International markets, Poland and Germany A: Poland saw temporary demand drops, Germany has competition but strong patient demand and vertical integration.

Q: Hemp-derived THC beverages regulatory risk A: Cautious expansion, smart regulation advocacy, and focus on states with codified rules.

Q: Beer distribution consolidation and cannabis capacity A: Analysis of distributor consolidation for cost savings, and capacity expansion for strategic supply and profitability.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-0.10$-0.04-150.0%$-0.12
Revenue$185.8M$249.7M-25.6%$188.3M

Transcript

April 8, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.